Kenvue

Investors are tracking Kenvue Inc., the consumer health company behind brands like Tylenol and Neutrogena, as its stock price and trading activity draw attention on financial platforms. Kenvue, spun off from Johnson & Johnson in 2023, has faced pressure from slowing sales and activist investor interest, making its share performance a talking point for market watchers.

Kenvue-owned skincare brands Neutrogena and Aveeno, alongside hair-loss treatment Regaine, have presented new scientific evidence on how their science-backed ingredients support healthy skin and hair. The announcement highlights research into ingredient effectiveness, part of the companies' ongoing effort to promote dermatological credibility and product innovation to consumers and health professionals.